Dr. Stanley Vogel Enrolls 1,000th Patient in Clinical Research Treatment Trial

Dr. Stanley Vogel, a medical oncologist at Cotton-O'Neil Cancer Center and long-time clinical researcher, has enrolled his 1,000th patient in a clinical research trial. Dr. Vogel has been involved in clinical research trials for more than 30 years and was one of the first physicians in the Topeka area to participate in research trials.

"Dr. Vogel is known for his dedication and commitment to his patients and those he has treated in clinical research trials. To reach a milestone like this is phenomenal," said Maynard Oliverius, president and chief executive officer of Stormont-Vail HealthCare. "Dr. Vogel has furthered the quality of care for patients with cancer for many years to come because of his participation and oversight of clinical trials."

Clinical research trials are health-related research studies done with people that follow a specific protocol to measure the outcome of a treatment or other invention. Results of studies can become new standards for treatment and lay the groundwork for the next study.
Dr. Vogel has participated in Southwest Oncology Group (SWOG) trials since 1978 and has registered patients predominantly in treatment trials. He is responsible for the treatment and follow-up for the patients while they are on trial. He also served on SWOG committees and has served as an auditor on quality of life SWOG site visits.

Dr. Vogel was also the physician in charge of the Topeka study center for a SELECT study, which was a prostate cancer prevention trial that was a SWOG project sponsored by National Cancer Institute. SELECT is the acronym for Selenium and Vitamin E Cancer Prevention Trial and studied whether selenium and vitamin E could help prevent prostate cancer.

Under Dr. Vogel's guidance, the Cotton-O'Neil Cancer Center has developed a progressive clinical research program for patients with a diagnosis of cancer. It typically has 60 to 70 open research trials available to patients and provides screening to see if they match protocols and are interested in participating.

The Cotton-O'Neil Cancer Center was nationally recognized by the American Society of Clinical Oncology for its clinical research contributions.

The Cotton-O'Neil Cancer Center also became affiliated two years ago as a major clinical research partner of the Midwest Cancer Alliance, a network of cancer professionals dedicated to increasing access to the latest advancements in cancer care throughout the Heartland.

"Dr. Vogel is recognized nationally for his work with clinical trials. His work has enhanced the care of patients in the region for decades," said Dr. Gary C. Doolittle, medical director of the Midwest Cancer Alliance.

To get a current list of open clinical trials through the Cotton-O'Neil Cancer Center, go to: http://www.stormontvail.org/cancer_ctr/clinicalresearch/trials.html